Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

GSK and Genmab report topline data from pivotal head-to-head study of ofatumumab

May 21, 2014

MOR-208 receives FDA and EMA orphan drug designations

May 21, 2014

ADC Therapeutics and MedImmune to advance ADCT-401 into clinic

May 21, 2014

NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC

May 20, 2014

Helix BioPharma seeks Canadian clearance for study of L-DOS47

May 15, 2014

FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma

May 15, 2014

FDA grants fast track status to Prima BioMed's CVac program

May 12, 2014

Cellmid selects lead anti-MK antibody in oncology

May 12, 2014

PSMA MAb [177Lu]J-591 tested for treatment of metastatic solid tumors

May 12, 2014

New anticancer agents patented by Chinese scientists

May 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...